跳至主要内容
临床试验/CTRI/2024/07/071543
CTRI/2024/07/071543尚未招募2/3 期

A Randomized Controlled Clinical Trial To Evaluate The Efficacy of Devdarvyadi Churna In The Management Of Vatashthila w.s.r. To BPH (Benign Prostate Hyperplasia)

Dr Rushda Nazir Ahmed Karjikar1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年8月9日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
To study the efficacy of Devdarvyadi Churna in the management of Vatashthila w.s.r to BPH

研究概览

简要总结

Title:- A Randomized Controlled Clinical Trial To Evaluate The Efficacy Of Devdarvyadi Churna In The Management Of Vatashthila w.s.r. To BPH (Benign Prostate Hyperplasia).

Null Hypothesis:-**Devdarvyadi Churnais not significantly effective in Vatashthila (BPH).

Alternate Hypothesis:- Devdarvyadi Churna is significantly effective in Vatashthila(BPH).

Study design:- Simple Randomized Controlled Clinical Trial.

Inclusive Criteria:-

  1. Age: Patients age between 45 to 70 years.

  2. Patients with mild and moderate symptoms as per American Urological Association score (IPSS) given for BPH.

  3. Patients having samanya lakshana(Symptoms) of Vatashthila(BPH).

  4. Patients will be included irrespective of their caste, religion, economic status, occupation.

  5. Patients only those who are ready to give written consent will be selected.

Exclusive Criteria:-

  1. Age: Patients age less than 45 years and more than 70 years.

  2. Patients having – Acute urinary retention, Stricture of Urethra, Carcinoma of Prostate, Bladder polyp, Hydronephrosis, Congenital contracture of Bladder neck, Carcinoma of Urinary tract, Neurogenic bladder.

  3. Patients with severe systemic diseases like- Renal failure, Cardiovascular disorders, uncontrolled diabeties mellitus and hypertension, Tuberculosis, HIV- Immuno compromised patients.

  4. Patients those who are not ready to give written consent.

Sample size:- Total 60 (30 for each group).

Patients coming in OPD and IPD of Shalyatantra department of our hospital with complaints of Vatashtila(BPH). Simple randomized sampling ( Lottery Method).

Group A:- Devdarvyadi Churna.

Group B:- Tab. Himplasia.

Total duration of drug administration is 90 days. The mode of drug administration will be by oral route.

Followup:- Followup will be done on 15th,30th & 90th day.

Result:- Result will be drawn as per assessment criteria & statistical analysis.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
45.00 Year(s) 至 70.00 Year(s)(—)
性别
Male

入选标准

  • Patients with mild and moderate symptoms as per American Urological Association score (IPSS) given for BPH.
  • Patients having samanya lakshana(Symptoms) of Vatashthila(BPH).
  • Patients will be included irrespective of their caste, religion, economic status, occupation.
  • Patients only those who are ready to give written consent will be selected.

排除标准

  • Patients having – Acute urinary retention, Stricture of Urethra, Carcinoma of Prostate, Bladder polyp, Hydronephrosis, Congenital contracture of Bladder neck, Carcinoma of Urinary tract, Neurogenic bladder.
  • Patients with severe systemic diseases like- Renal failure, Cardiovascular disorders, uncontrolled diabetes mellitus and hypertension, Tuberculosis, HIV- Immuno compromised patients.
  • Patients those who are not ready to give written consent.

结局指标

主要结局

To study the efficacy of Devdarvyadi Churna in the management of Vatashthila w.s.r to BPH

时间窗: 90 days study with | Follow-up on- 15th ,30th ,90th day

次要结局

  • 1) To study the etiopathogenesis of Vatashthila w.s.r to BPH(2)To study the Literature of Devdarvyadi Churna)

研究者

发起方
Dr Rushda Nazir Ahmed Karjikar
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Rushda Nazir Ahmed Karjikar

MES Ayurved Mahavidyalaya

研究点 (1)

Loading locations...

相似试验

A Clinical Study To Evaluate The Efficacy of... | 临床试验